Statins in Heart Failure—Where Do We Stand?

By Lyons Kristopher   McVeigh Gary   Harbinson Mark  

Cardiovascular Drugs and Therapy, Vol. 25, Iss. 1, 2011-02 ,pp. : 99-104

Springer Publishing Company

Access to resources Recommend Favorite

Can we improve the treatment of congestion in heart failure?

By Metra Marco   Bugatti Silvia   Bettari Luca   Carubelli Valentina   Danesi Rossella   Lazzarini Valentina   Lombardi Carlo   Cas Livio Dei  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 9, 2011-06 ,pp. : 1369-1379

Informa Healthcare

Access to resources Recommend Favorite

ACE Inhibitors in Heart Failure: What More Do We Need to Know?

By Demers Catherine   Mody Anita   Teo Koon K.   McKelvie Robert S.  

American Journal of Cardiovascular Drugs, Vol. 5, Iss. 6, 2005-01 ,pp. : 351-359

Adis International

Access to resources Recommend Favorite

Genome-wide association studies of coronary artery disease and heart failure: where are we going?

By Dorn Gerald W   Cresci Sharon  

Pharmacogenomics, Vol. 10, Iss. 2, 2009-02 ,pp. : 213-223

Future Medicine

Access to resources Recommend Favorite

Drugs, Heart Failure and Quality of Life: What Are We Achieving? What Should We Be Trying to Achieve?

By Doba N.   Tomiyama H.   Nakayama T.  

Drugs & Aging, Vol. 14, Iss. 3, 1999-03 ,pp. : 153-163

Adis International

Access to resources Recommend Favorite